This action will reload the page results.
Journal article
Effectiveness, biomarker transition, and safety of 48-week tralokinumab treatment for atopic dermatitis: real-world analyses stratified by age groups (15-17, 18-64, and ≥ 65 years)
- By Yohei Takahashi,
- Teppei Hagino,
- Akihiko Uchiyama,
- et al.
In European Journal of Dermatology (2026/2 Vol. 36)